HER2+ Inflammatory Breast Cancer: Neoadjuvant Approaches
0 Visualizzazioni
• 07/03/23
0
0
Incorporare
administrator
Iscritti
Debu Tripathy, MD, shares insight on the optimal neoadjuvant approaches to HER2+ inflammatory breast cancer with regard to the availability of hormonal and chemotherapeutic agents.
For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/
Mostra di più
Commenti su Facebook
SORT BY-
I migliori commenti
-
Ultimi commenti